Spleen Amaranth
Amaranthus dubius seeds and leaves contain bioactive peptides, flavonoids (quercetin, rutin, kaempferol), and phenolic acids that exert antioxidant activity via free-radical scavenging and ferric ion reduction, while seed protein isolates also demonstrate antibacterial action against E. coli and S. aureus through size-specific peptide fractions. In vitro assays of seed protein isolates record DPPH radical scavenging at 56.65 ± 0.027 µg AAE/mg and iron chelation at 32.03%, reflecting meaningful redox-modulating capacity, though these findings have not yet been confirmed in human clinical trials.

Origin & History
Amaranthus dubius is native to tropical and subtropical regions of the Americas but has naturalized extensively across sub-Saharan Africa, South Asia, and the Caribbean, thriving in disturbed soils, roadsides, and agricultural margins at low to mid elevations. It grows as a warm-season annual weed-crop tolerant of heat, moderate drought, and poor soil fertility, making it accessible to subsistence communities throughout Southern Africa and India. The plant is cultivated semi-formally as a leafy vegetable in Zimbabwe, South Africa, and parts of East Africa, where it is harvested as both a food source and a medicinal herb.
Historical & Cultural Context
Amaranthus dubius has been integrated into the food and medicinal traditions of Southern and Eastern Africa, where it is locally called 'bonongwe' in Zimbabwe and similar vernacular names across the region, and harvested from wild-growing populations as a famine food and everyday vegetable. In traditional Southern African medicine, the plant is prepared as a decoction or poultice to treat gastrointestinal infections, inflammatory conditions, and fever, reflecting its perceived anti-infective and antipyretic properties. In South Asian folk medicine, particularly in India, Amaranthus species including A. dubius have similarly been employed for pain relief and fever reduction, underscoring convergent ethnomedicinal knowledge across geographically separated traditions. Pre-Columbian Mesoamerican cultures held Amaranthus grains in sacred regard, and while A. dubius is distinct from grain amaranths, its spread across Africa and Asia followed colonial-era agricultural and trade movements that relocated many New World plant species into subsistence farming systems.
Health Benefits
- **Antioxidant Protection**: Seed protein isolates of A. dubius exhibit DPPH scavenging activity of 56.65 µg AAE/mg and ABTS scavenging of 31.37 µg AAE/mg, with these effects attributed to bioactive peptides that donate hydrogen atoms to neutralize reactive oxygen species. - **Antibacterial Activity**: Alcalase-derived peptide fractions below 3 kDa inhibit E. coli growth, while chymotrypsin-derived fractions in the 10–50 kDa range suppress S. aureus, suggesting fraction-specific membrane disruption or enzymatic interference as a mechanism. - **Exceptional Micronutrient Density**: The leaves contain approximately 20-fold more calcium, 7-fold more iron, 13-fold more vitamin C, and 18-fold more beta-carotene than lettuce, making A. dubius a candidate functional food for addressing micronutrient deficiencies in food-insecure populations. - **Anti-inflammatory and Antipyretic Potential**: Amaranthus species have been used ethnobotanically to reduce fever and relieve pain, effects hypothetically linked to phenolic acid content (salicylic, ferulic, and p-coumaric acids) that may modulate prostaglandin synthesis pathways. - **Digestive Health Support**: Traditional Southern African use includes treatment of gastrointestinal complaints; the high dietary fiber content of leaves combined with phenolic compounds may support gut motility and suppress enteric pathogens. - **Iron and Calcium Bioavailability**: The elevated iron and calcium concentrations in leaves, when consumed with vitamin C-rich foods, may support erythropoiesis and bone mineralization, though bioavailability is modulated by co-occurring oxalates and antinutrients requiring preparation-based mitigation. - **Membrane Stabilization**: Seed protein isolates demonstrate membrane stabilization activity of 25.56 ± 0.045%, a proxy for anti-inflammatory capacity, indicating potential for reducing cellular membrane damage under oxidative or inflammatory stress.
How It Works
The antioxidant activity of A. dubius seed peptides operates through multiple non-enzymatic pathways: hydrogen atom transfer and single electron transfer mechanisms underlie the DPPH and ABTS scavenging activity, while Fe²⁺ chelation (32.03%) sequesters pro-oxidant transition metals before they catalyze Fenton-type hydroxyl radical generation. Chymotrypsin-derived peptides larger than 50 kDa demonstrate the strongest DPPH scavenging, whereas alcalase hydrolysates in the 10–50 kDa range show superior ABTS scavenging, indicating that peptide chain length and hydrophobicity govern which radical species are preferentially neutralized. The antibacterial mechanism of sub-3 kDa alcalase fractions against E. coli likely involves disruption of the gram-negative outer membrane, while the 10–50 kDa chymotrypsin fractions targeting S. aureus may interfere with cell wall synthesis or membrane integrity via amphipathic structural interactions. Phenolic compounds including quercetin, kaempferol, and rutin present in leaves can inhibit pro-inflammatory enzymes such as cyclooxygenase and lipoxygenase, and quercetin additionally modulates NF-κB signaling, though these mechanisms have not been specifically confirmed for A. dubius isolates in controlled biochemical studies.
Scientific Research
The available evidence for Amaranthus dubius is limited primarily to in vitro studies examining seed protein isolates and leaf phytochemical profiles, with no published human randomized controlled trials identified in the current literature. Key published work has characterized antioxidant capacity of enzymatic hydrolysates using DPPH, ABTS, FRAP, and Fe²⁺ chelation assays, and has identified antibacterial activity of size-fractionated peptides against E. coli and S. aureus in culture-based models. Broader ethnobotanical surveys document traditional use in Southern Africa and India, but these surveys do not constitute controlled efficacy evidence. The research consensus explicitly identifies A. dubius seeds as a promising nutraceutical and pharmaceutical source while calling for future bioavailability, pharmacokinetic, and clinical efficacy studies to translate in vitro findings into therapeutic recommendations.
Clinical Summary
No human clinical trials have been conducted specifically on Amaranthus dubius extracts, isolates, or standardized preparations as of the current literature review. The evidence base consists of in vitro bioactivity studies demonstrating antioxidant, antibacterial, and membrane-stabilizing properties of seed protein fractions, and cross-species nutritional analyses comparing leaf micronutrient content to reference vegetables. While related Amaranthus species (e.g., A. cruentus, A. hypochondriacus) have been studied in small human nutrition trials examining lipid profiles and glycemic response, these findings cannot be directly extrapolated to A. dubius without species-specific clinical data. Confidence in therapeutic claims for this specific species remains low pending human trial data, though its nutritional profile provides a rational basis for further investigation in food-security and anti-infective research contexts.
Nutritional Profile
Leaves of Amaranthus dubius are exceptionally micronutrient-dense: calcium content is approximately 20-fold higher than lettuce, vitamin C approximately 13-fold higher, iron approximately 7-fold higher, and beta-carotene approximately 18-fold higher, positioning the plant as a high-value functional food for populations at risk of micronutrient deficiency. Seeds contain significant quantities of protein with a favorable amino acid profile typical of the Amaranthus genus, including meaningful concentrations of lysine, an amino acid limiting in most cereal grains. Phytochemical composition includes flavonols (quercetin, isoquercetin, rutin, kaempferol, myricetin, hyperoside), flavones (apigenin), and phenolic acids (salicylic, gallic, syringic, vanillic, ferulic, and p-coumaric acids). Bioavailability of iron and calcium may be reduced by co-occurring oxalic acid and phytic acid; traditional cooking methods such as boiling and discarding water partially degrade these antinutrients, improving mineral accessibility.
Preparation & Dosage
- **Fresh Leaves (Food Use)**: Consumed as a cooked green vegetable in Southern African and South Asian cuisines; steaming or brief boiling is recommended to reduce oxalate content while preserving heat-stable minerals and beta-carotene. - **Leaf Decoction (Traditional Medicinal)**: Leaves are boiled in water for 10–20 minutes to produce a tea-like decoction used in Southern African traditional medicine for digestive complaints and fever; no standardized dose has been established in clinical literature. - **Dried Leaf Powder**: Used regionally as a food supplement; no commercially standardized extract or capsule form with defined A. dubius content is widely available as of the current literature. - **Seed Protein Isolate (Research Grade)**: Enzymatic hydrolysates used in in vitro studies are produced via alcalase or chymotrypsin digestion followed by ultrafiltration into size-defined fractions (<3 kDa, 10–50 kDa, >50 kDa); these are not commercially available as consumer supplements. - **Dosage Guidance**: No evidence-based supplemental dose exists; as a food vegetable, consumption of 50–150 g fresh weight of cooked leaves provides meaningful micronutrient intake; medicinal dosing should not be self-directed without healthcare practitioner guidance given the absence of safety trials.
Synergy & Pairings
The vitamin C content of A. dubius leaves (approximately 13-fold higher than lettuce) acts synergistically with its non-heme iron, as ascorbic acid reduces Fe³⁺ to the more bioavailable Fe²⁺ form and forms a chelate complex that resists inhibition by phytates, substantially enhancing iron absorption when the whole leaf is consumed. Combining A. dubius leaf preparations with quercetin-rich foods (e.g., onion or apple) may amplify NF-κB inhibition and antioxidant enzyme induction, as quercetin from multiple dietary sources acts additively on shared inflammatory signaling pathways. In traditional culinary stacking, A. dubius is often cooked with groundnut (peanut) paste in Southern African recipes, and the fat content of groundnut enhances absorption of the fat-soluble carotenoids (beta-carotene) present in the leaves.
Safety & Interactions
Amaranthus dubius has a long history of safe consumption as a leafy vegetable across Africa and Asia, and no acute toxicity events from food-level consumption have been documented in the literature; however, formal toxicological dose-escalation studies and maximum tolerable dose data are absent. The leaves contain oxalic acid, which at high habitual intake could contribute to calcium oxalate kidney stone formation in susceptible individuals, particularly those with pre-existing renal insufficiency or hyperoxaluria. No specific drug interaction studies for A. dubius exist; theoretically, high vitamin K content in leaves could attenuate anticoagulant therapy (e.g., warfarin), and the iron content may interact with tetracycline or fluoroquinolone antibiotics by chelation if consumed simultaneously. Pregnant and lactating women should restrict use to culinary food quantities rather than concentrated extracts or decoctions, as no safety data exist for medicinal-dose use during pregnancy; individuals with known amaranth or chenopod family allergies should exercise caution.